• ქართული
  • English
  • Starboard to vote against Bristol-Myers-Celgene $74 billion deal

    Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co’s $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, adding to the number of shareholders declaring against the deal.

    Market Quotes by TradingView